Latest Sunitinib Stories
Data Support Adoption of Stable Disease as Response Criterion, Raise Intriguing Hypotheses about Sequential Therapy and Utility of IL-2 as Salvage Option CHICAGO, May 31, 2014 /PRNewswire/
WHIPPANY, N.J., May 14, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
LONDON, May 6, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, April 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
WHIPPANY, N.J., Feb.
A recent study featured in the latest issue of The Oncologist shows that active smoking greatly diminishes patients’ chances of responding to chemotherapeutic treatment for renal cell carcinoma